Pamela Russell

Q: What Schools Are Affiliated With Pamela Russell

Pamela Russell is affiliated with the following schools: Queensland University of Technology, University of Queensland, University of New South Wales, University of Sydney, University of Melbourne, Monash University

Pamela Russell's AcademicInfluence.com Rankings

Pamela Russell

Biology

#9164

World Rank

#12334

Historical Rank

Immunology

#545

World Rank

#563

Historical Rank

biology Degrees

Download Badge

Biology

Pamela Russell's Degrees

PhD Immunology University of Melbourne

Why Is Pamela Russell Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Pamela J. Russell was an Australian academic researcher of immunology, bladder and prostate research. Russell was awarded Membership of the Order of Australia for her research on prostate and bladder cancer in 2003.

(See a Problem?)

Pamela Russell's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum (2003) (428)
Biology and management of bladder cancer. (1990) (418)
Influence of cellular DNA content on survival in advanced ovarian cancer. (1984) (289)
Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancer (1999) (245)
Growth factor involvement in progression of prostate cancer. (1998) (236)
Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer (1997) (189)
Classification of Human-Tumors by High-Resolution Magnetic-Resonance Spectroscopy (1986) (187)
Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. (2003) (182)
Observation of a kilogram-scale oscillator near its quantum ground state (2009) (151)
THE ROLE OF NONLYMPHOID ACCESSORY CELLS IN THE IMMUNE RESPONSE TO DIFFERENT ANTIGENS (1970) (148)
Setting upper limits on the strength of periodic gravitational waves from PSR J1939+2134 using the first science data from the GEO 600 and LIGO detectors (2004) (148)
Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. (1997) (142)
Emerging roles for phospholipase A2 enzymes in cancer. (2010) (131)
The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. (2005) (131)
Upper limits on gravitational wave emission from 78 radio pulsars (Physical Review D - Particles, Fields, Gravitation and Cosmology (2007) 76, (042001)) (2007) (126)
Ploidy as a Prognostic Factor in Ovarian Cancer (1983) (125)
Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer. (1988) (124)
Engineered silk fibroin protein 3D matrices for in vitro tumor model. (2011) (123)
Limits on gravitational-wave emission from selected pulsars using LIGO data. (2004) (123)
Hormone replacement therapy and risk of epithelial ovarian cancer (1999) (119)
Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine‐needle aspirates analysed using a statistical classification strategy (2001) (119)
Searches for periodic gravitational waves from unknown isolated sources and Scorpius X-1: Results from the second LIGO science run (2006) (116)
MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer (2005) (116)
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors (2008) (116)
Urokinase‐type plasminogen activator and its receptor in colorectal cancer: Independent prognostic factors of metastasis and cancer‐specific survival and potential therapeutic targets (2000) (112)
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression (2010) (112)
Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis (2006) (109)
Cyclophosphamide treatment of renal disease in (NZB x NZW) F1 hybrid mice. (1968) (103)
Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers. (1997) (103)
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer. (2016) (102)
Computerized Consensus Diagnosis: A Classification Strategy for the Robust Analysis of MR Spectra. I. Application to 1H Spectra of Thyroid Neoplasms (1995) (102)
Searching for a Stochastic Background of Gravitational Waves with the Laser Interferometer Gravitational-Wave Observatory (2007) (101)
Oncogenic Action of Secreted Phospholipase A2 in Prostate Cancer (2004) (98)
FLOW CYTOMETRIC ANALYSIS OF CELLULAR DNA CONTENT AS AN ADJUNCT TO THE DIAGNOSIS OF OVARIAN TUMOURS OF BORDERLINE MALIGNANCY (1984) (97)
Search for gravitational-wave bursts in LIGO data from the fourth science run (2007) (94)
Human prostate cancer cell lines. (2003) (93)
Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone. (2014) (92)
All-sky search for periodic gravitational waves in LIGO S4 data (Physical Review D - Particles, Fields, Gravitation and Cosmology (2008) 77, (022001)) (2008) (91)
Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver (2014) (91)
Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. (1993) (89)
Pathologic characterization of human prostate tissue with proton MR spectroscopy. (2003) (88)
Search for gravitational waves from low mass compact binary coalescence in 186 days of LIGO's fifth science run (2009) (86)
Changing character of cervical cancer in young women. (1989) (84)
PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer. (2015) (83)
Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer. (2006) (81)
Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer (2008) (81)
3D Cultures of Prostate Cancer Cells Cultured in a Novel High-Throughput Culture Platform Are More Resistant to Chemotherapeutics Compared to Cells Cultured in Monolayer (2014) (81)
Search for gravitational waves associated with the gamma ray burst GRB030329 using the LIGO detectors (2005) (80)
Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies (2004) (78)
Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. (1994) (76)
THE SEPARATION OF DIFFERENT CELL CLASSES FROM LYMPHOID ORGANS (1969) (76)
Bladder cancer xenografts: a model of tumor cell heterogeneity. (1986) (76)
Oncogenic action of phospholipase A2 in prostate cancer. (2006) (76)
Search for gravitational waves associated with 39 gamma-ray bursts using data from the second, third, and fourth LIGO runs (2008) (76)
Induction of Immunity and Tolerance in vitro in the Absence of Phagocytic Cells (1970) (74)
Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer (2003) (72)
Upper limits on a stochastic background of gravitational waves. (2005) (72)
Alterations of p53 are common in early stage prostate cancer. (2003) (70)
Cellular DNA content--a stable feature in epithelial ovarian cancer. (1984) (70)
Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle (2013) (68)
Multifoeal Tumorigenesis in the Upper Female Genital Tract—Implications for Staging and Management (1985) (67)
PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer (2013) (66)
Cyclophosphamide treatment of kidney disease in (NZB x NZW) F1 mice. (1966) (65)
Tissue engineered humanized bone supports human hematopoiesis in vivo. (2015) (65)
Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? (2010) (65)
Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology (2012) (64)
Relationship between radiation response and p53 status in human bladder cancer cells. (1997) (62)
Upper limits on gravitational wave bursts in LIGO's second science run (2005) (61)
Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy (2002) (61)
Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines (2003) (61)
Proton spectroscopy provides accurate pathology on biopsy and in vivo (2006) (61)
Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line. (1999) (61)
Upper limits from the LIGO and TAMA detectors on the rate of gravitational-wave bursts (2005) (60)
Localised delivery of doxorubicin to prostate cancer cells through a PSMA-targeted hyperbranched polymer theranostic. (2017) (60)
Proton MRS can determine the pathology of human cancers with a high level of accuracy. (2004) (60)
Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes, [(R)- and (S)-3-aminohexahydroazepine]dichloroplatinum(II). Crystal structure of the S enantiomer. (1997) (59)
Einstein@Home search for periodic gravitational waves in early S5 LIGO data (2009) (58)
Search for gravitational waves from binary black hole inspirals in LIGO data (2006) (58)
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality (2017) (58)
CLASSIFICATION OF HUMAN TUMOURS BY HIGH-RESOLUTION MAGNETIC RESONANCE SPECTROSCOPY (1986) (57)
Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Slows Cancer Development but Increases Metastases in TRAMP Prostate Cancer Prone Mice (2012) (56)
Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing. (1995) (55)
Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. (2001) (55)
Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer (1987) (55)
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer (2016) (55)
Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation (1988) (53)
Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines. (2004) (52)
Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity. (1990) (52)
Thymus-derived cells as killer cells in cell-mediated immunity. (1971) (51)
Uterine cervical punch biopsy specimens can be analyzed by 1h mrs (1990) (51)
Innovative biomarkers for prostate cancer early diagnosis and progression. (2010) (51)
IL-18 Inhibits Growth of Murine Orthotopic Prostate Carcinomas via Both Adaptive and Innate Immune Mechanisms (2011) (50)
KAI1 tetraspanin and metastasis suppressor. (2005) (49)
Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines. (2000) (49)
Modeling prostate cancer: a perspective on transgenic mouse models (2010) (48)
Evaluation of Ovarian Tumors by Proton Magnetic Resonance Spectroscopy at Three Tesla (2008) (48)
Flow cytometric and morphological studies of ovarian carcinoma cell lines and xenografts. (1983) (46)
Xenografted small cell undifferentiated cancer of prostate: Possible common origin with prostatic adenocarcinoma (1987) (46)
Accurate diagnosis and prognosis of human cancers by proton MRS and a three-stage classification strategy (2002) (46)
Studies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. (1983) (45)
Differentation of foetal mouse thymus. Ultrastructure of organ cultures and of subcapsular grafts. (1971) (45)
Development of a polymer theranostic for prostate cancer (2014) (44)
Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism (2013) (43)
Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer. (2010) (43)
Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice (2006) (42)
A novel model of bone‐metastatic prostate cancer in immunocompetent Mice (2009) (42)
Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. (2004) (41)
Gene‐directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease (2004) (41)
Joint LIGO and TAMA300 search for gravitational waves from inspiralling neutron star binaries (2006) (41)
Search for gravitational-wave bursts in LIGO's third science run (2006) (41)
Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study. (2002) (40)
On the diagnosis of minimal breast cancer in a screenee population (1976) (40)
Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy. (1995) (40)
Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1 (2015) (39)
Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression. a review of the evidence. (2001) (38)
Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon α (2003) (38)
Metastasizing placental site trophoblastic tumor: a case study. (1985) (38)
Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment. (2004) (38)
The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression (2008) (38)
Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines. (2000) (38)
Is a Klebsiella plasmid involved in the aetiology of Ankylosing Spondylitis in HLA-B27-positive individuals? (1983) (37)
Argyrophilia and Endometrial Carcinoma (1983) (37)
Magnetic resonance spectroscopy detects cancer in draining lymph nodes. (1993) (37)
Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines. (1999) (37)
Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors (1996) (35)
Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer (2000) (35)
Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology (2008) (35)
STACKED SEARCH FOR GRAVITATIONAL WAVES FROM THE 2006 SGR 1900+14 STORM (2009) (35)
Flow cytometric and karyotypic analysis of a primary small cell carcinoma of the prostate: a xenografted cell line. (1987) (35)
Molecular profiling of bladder cancer: involvement of the TGF-beta pathway in bladder cancer progression. (2008) (35)
The Use of Proton MR in Cancer Pathology (1993) (34)
Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer. (1985) (34)
Genomic alterations (LOH, MI) on chromosome 17q21–23 and prognosis of sporadic colorectal cancer (2000) (34)
Evaluation of Polymeric Nanomedicines Targeted to PSMA: Effect of Ligand on Targeting Efficiency. (2015) (34)
The Use of Proton MR in Cancer Pathology (1993) (34)
Expression of cell regulatory proteins in ovarian borderline tumors (1996) (34)
Preparation, characterization, cytotoxicity, and mutagenicity of a pair of enantiomeric platinum(II) complexes with the potential to bind enantioselectively to DNA. (1993) (34)
Promising tumor‐associated antigens for future prostate cancer therapy (2010) (33)
Purine nucleoside phosphorylase and fludarabine phosphate gene‐directed enzyme prodrug therapy suppresses primary tumour growth and pseudo‐metastases in a mouse model of prostate cancer (2004) (32)
Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression (2003) (32)
Transcription-targeted gene therapy for androgen-independent prostate cancer (2002) (32)
Two-Dimensional Proton Magnetic Resonance Spectroscopy for Tissue Characterization of Thyroid Neoplasms (1996) (32)
Establishing Prostate Cancer Patient Derived Xenografts: Lessons Learned From Older Studies (2015) (31)
Characterization of human ovarian epithelial tumors (ex vivo) by proton magnetic resonance spectroscopy (1994) (31)
Establishing Prostate Cancer Patient Derived Xenografts: Lessons Learned From Older Studies (2015) (31)
Label-free isolation of a prostate cancer cell among blood cells and the single-cell measurement of drug accumulation using an integrated microfluidic chip. (2015) (30)
Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay. (1989) (30)
Ectopic hormone production by a prostatic small cell carcinoma xenograft line (1988) (30)
Ectopic hormone production by a prostatic small cell carcinoma xenograft line (1988) (30)
Multifunctional core-shell magnetic cisplatin nanocarriers. (2009) (30)
Zoledronic Acid Preserves Bone Structure and Increases Survival but Does Not Limit Tumour Incidence in a Prostate Cancer Bone Metastasis Model (2011) (29)
All-sky search for periodic gravitational waves in LIGO S4 data [Phys. Rev. D 77, 022001 (2008)][Publisher's note] (2008) (27)
Molecular and traditional chemotherapy: a united front against prostate cancer. (2010) (26)
Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted alpha-therapy with 213Bi-conjugates. (2004) (26)
Antiproliferative effects of bacillus Calmette-Guérin and interferon α2b on human bladder cancer cells in vitro (1995) (26)
Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease. (2016) (26)
Preparation, characterization, DNA binding, and in vitro cytotoxicity of the enantiomers of the platinum(II) complexes N-methyl-, N-ethyl- and N,N-dimethyl-(R)- and -(S)-3-aminohexahydroazepinedichloroplatinum(II). (1997) (26)
Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop (2015) (25)
Characterization of cell lines derived from a multiply aneuploid human bladder transitional‐cell carcinoma, UCRU‐BL‐13 (1989) (25)
Cytogenetic findings in cell lines derived from four ovarian carcinomas. (1987) (25)
Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206 (2008) (25)
The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors. (1989) (25)
Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer (2017) (25)
Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines. (2002) (24)
Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By 213Bilabeled Multiple Targeted α Radioimmunoconjugates (2009) (24)
Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma. (1988) (24)
A joint search for gravitational wave bursts with AURIGA and LIGO (2008) (24)
Site‐specific growth of the prostate xenograft line UCRU‐PR‐2 (1989) (23)
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer (2014) (23)
Astrophysically triggered searches for gravitational waves: status and prospects (2008) (23)
Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies. (2003) (23)
Site‐specific growth of the prostate xenograft line UCRU‐PR‐2 (1989) (23)
Cancer pathology in the year 2000. (1997) (22)
Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway (2019) (22)
Derivation of MPR and TRAMP models of prostate cancer and prostate cancer metastasis for evaluation of therapeutic strategies. (2002) (22)
From Bench to Bedside: Immunotherapy for Prostate Cancer (2014) (22)
Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Gene Deletion Promotes Cancer Growth in TRAMP Prostate Cancer Prone Mice (2015) (22)
Prevalence of PD-L1 expression in matched recurrent and/or metastatic sarcoma samples and in a range of selected sarcomas subtypes (2020) (22)
Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens (2003) (22)
Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy. (2003) (21)
Tie-2 regulates the stemness and metastatic properties of prostate cancer cells (2015) (21)
Novel gene-directed enzyme prodrug therapies against prostate cancer (2006) (21)
Role of the Akt pathway in prostate cancer. (2009) (21)
Control of prostate cancer spheroid growth using 213Bi‐labeled multiple targeted α radioimmunoconjugates (2006) (21)
Human cancers detected by proton MRS and chemical shift imaging ex vivo. (1996) (21)
Failure of Klebsiella pneumoniae antibodies to cross-react with peripheral blood mononuclear cells from patients with ankylosing spondylitis. (1987) (20)
Elastase activities of human bladder cancer cell lines derived from high grade invasive tumours. (1989) (20)
Magnetic nanoparticles: prospects in cancer imaging and therapy. (2007) (20)
Targeted α-therapy for control of micrometastatic prostate cancer (2004) (18)
Tumour‐induced host stromal‐cell transformation: Induction of mouse spindle‐cell fibrosarcoma not mediated by gene transfer (1990) (18)
Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody (2004) (18)
Proton magnetic resonance and human thyroid neoplasia II: Potential avoidance of surgery for benign follicular neoplasms (1994) (18)
Studies of Autologous Mixed Lymphocyte Reactions in Patients with Systemic Lupus Erythematosus (1983) (18)
Tumour‐induced host stromal‐cell transformation: Induction of mouse spindle‐cell fibrosarcoma not mediated by gene transfer (1990) (18)
Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: significant correlation with malignant potential (2004) (18)
Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: A single centre study in 987 patients (2010) (17)
Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway (2007) (17)
Serum proteins neutralize the toxic effect of lysophosphatidyl choline. (1982) (17)
Radiotherapy in larynx squamous cell carcinoma is not associated with an increased diagnosis of second primary tumours. (2009) (17)
Evidence for post‐transcriptional down‐regulation of the apoptosis‐related gene bcl‐2 in human colorectal cancer (2000) (17)
Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats (1991) (16)
Evaluation of an in vitro invasion assay for use on solid tissue samples and cultured cells. (1992) (16)
Molecular biology of urological tumours. (1990) (16)
Increased targeting of adenine-rich sequences by (2-amino-2-methyl-3-butanone oxime)dichloroplatinum(II) and investigations into its low cytotoxicity (2000) (16)
Cytosine Deaminase-Uracil Phosphoribosyltransferase and Interleukin (IL)-12 and IL-18: A Multimodal Anticancer Interface Marked by Specific Modulation in Serum Cytokines (2009) (15)
Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines. (2005) (14)
Elevated levels of prostate‐specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis (2003) (14)
Extracellular Vesicles in the Adaptive Process of Prostate Cancer during Inhibition of Androgen Receptor Signaling by Enzalutamide (2017) (14)
Failure to transfer haemolytic anaemia or glomerulonephritis with cell-free material from NZB mice. (1970) (14)
Erlotinib (OSI‐774)‐induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon‐α (2007) (14)
Molecular Chemotherapy and Chemotherapy: A New Front against Late-Stage Hormone-Refractory Prostate Cancer (2011) (14)
Paclitaxel suppresses the growth of primary prostate tumours (RM-1) and metastases in the lung in C57BL/6 mice. (2006) (13)
Cytostatic and cytolytic activities of macrophages regulation by prostaglandins. (1984) (13)
An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines. (2012) (13)
Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. (2005) (13)
The early antibody-forming response to Salmonella antigens. A study of morphology and kinetics in vivo and in vitro. (1970) (13)
Dosimetric and therapeutic studies in nude mice xenograft models with 153Samarium-labelled monoclonal antibody, BLCA-38 (1991) (13)
Heterogeneity of in vitro radiosensitivity in human bladder cancer cells. (1999) (13)
Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer (2008) (13)
Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: A tangible union against chemoresistant cancer (2011) (13)
Interferon-α Promotes the Anti-Proliferative Effect of Gefitinib (ZD1839) on Human Colon Cancer Cell Lines (2005) (13)
Characterization of a new human bladder cancer cell line, UCRU-BL-28. (1993) (13)
Use of polymerase chain reaction to diagnose a natural outbreak of mouse hepatitis virus infection in nude mice. (1998) (12)
Sequential cytogenetic studies in an ovarian cancer cell line. (1989) (12)
Two homologous mixed Müllerian tumor lines of the ovary and their characteristics (1990) (12)
Radiotherapy is not associated with an increased rate of Second Primary Tumours in Oral Squamous Carcinoma: a study of 370 patients. (2009) (12)
Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing (1992) (12)
Plant-derived MINA-05 inhibits human prostate cancer proliferation in vitro and lymph node spread in vivo. (2007) (11)
Studies of Macrophage Function in Murine Systemic Lupus Erythematosus. 3. The Nature, Anatomical Location, and Reversibility of the Phagocytic Defect (1986) (11)
Prognosis and prognostic factors in node‐negative cervix cancer (1996) (11)
Enhancement of biological effectiveness of radiotherapy treatments of prostate cancer cells in vitro using gold nanoparticles (2011) (11)
Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1) (2020) (11)
Elevated expression of FGF‐2 does not cause prostate cancer progression in LNCaP cells (1999) (11)
The role of suppressor T cells in the expression of autoimmune haemolytic anaemia in NZB mice. (1981) (10)
Biology of Human Tumors Genomic Classi fi cation of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP 53-Mutant Tumors and Identi fi es NRAS as an Oncogenic Driver (2014) (10)
Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines. (2005) (10)
Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone (2018) (10)
Murine CTLL-2 cells respond to mIL12: prospects for developing an alternative bioassay for measurement of murine cytokines IL12 and IL18. (2007) (10)
Protein Markers in Colorectal Cancer (1999) (10)
Chemical Shift Imaging of Human Colorectal Tissue (Ex Vivo) (1996) (10)
Absolute quantification of human tear lactoferrin using multiple reaction monitoring technique with stable-isotopic labeling. (2015) (9)
Proton magnetic resonance and human cervical neoplasia. II. Ex vivo chemical-shift microimaging. (1996) (9)
The use of monoclonal antibodies for the diagnosis and therapy of bladder cancer. (1993) (9)
Regulation and deregulation of G2 checkpoint proteins with cisplatin. (1998) (9)
Animal models of prostate cancer. (2003) (9)
Studies of Peritoneal Macrophage Function in Murine Systemic Lupus Erythematosus. 2. Nature of Elevated Resident Peritoneal Cells in NZB and (NZB × NZW)F1 Mice (1985) (9)
Features of squamous and adenocarcinoma in the same cell in a xenografted human transitional cell carcinoma: Evidence of a common histogenesis? (2004) (9)
Breast cancer screening: Preliminary report of 207 biopsies performed in 4,128 volunteer screenees (1975) (8)
Macrophage inhibitory cytokine-1 (MIC-1) in epithelial neoplasia (2001) (8)
Breast cancer screening: Preliminary report of 207 biopsies performed in 4,128 volunteer screenees (1975) (8)
Experimental models of histogenesis and tumor cell heterogeneity in bladder cancer. (1992) (7)
Prostate cancer gene therapy (1998) (7)
Mitogen-induced suppressor factor(s) from human lymphocytes: effects on lymphoid and nonlymphoid cells and biophysical properties. (1982) (7)
Applications of the xenograft as a model of invasive transitional cell carcinoma of the bladder. (1988) (7)
Antigenic Variation and Macrophage Infiltration of Human Bladder Tumors Xenografted Into Nude Mice (1988) (7)
Studies of Macrophage Function in Murine Systemic Lupus Erythematosus. 4. Failure to Reverse the Defect in Fc‐Mediated Phagocytosis and Binding by in Vitro Stimulants or Prostaglandins (1986) (7)
Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer (2011) (7)
Expression of nm23 protein in adult soft tissue sarcoma is correlated with histological grade. (2003) (7)
Prostate Cancer: Methods and Protocols (2018) (7)
Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer. (2002) (7)
Proton magnetic resonance and human cervical neoplasia (1994) (7)
Targeting aurora kinases: a novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer. (2012) (7)
Studies of X-irradiated bladder cancer cell lines showing differences in p53 status: absence of a p53-dependent cell cycle checkpoint pathway. (1996) (7)
Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck * (2009) (7)
Targeted alpha therapy of prostate cancer. (2003) (6)
An in vitro study of ovarian atypical proliferating (borderline) serous tumors (1991) (6)
No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers. (2004) (6)
Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer (2009) (6)
Human Group IIA Phospholipase A2—Three Decades on from Its Discovery (2021) (6)
Alterations to the protein profile of bladder carcinoma cell lines induced by plant extract MINA‐05 in vitro (2009) (6)
Reliable method of isolating transfected clones from the LNCaP human prostatic cell line. (1997) (6)
568 PSMA pet improves diagnostic accuracy of mpMRI in localised prostate cancer as confirmed by whole mount histopathology: Implications for selection and assessment for active surveillance and focal therapy (2016) (6)
In Vivo Spectroscopy and Imaging of the Ovary In Vivo at 3 Tesla and Spectroscopy on Biopsy at 8.5 Tesla (2005) (6)
Proton magnetic resonance and human thyroid neoplasia III. Ex vivo chemical-shift microimaging. (1996) (5)
Changing character of cervical cancer in young women. (1989) (5)
Analysis of expressed N-ras mutations in human melanoma short-term cell lines with allele specific restriction analysis induced by the polymerase chain reaction. (1992) (5)
Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease (2021) (5)
Second Primary Tumours of the Head and Neck are not Associated with Adverse Overall Survival in Oral Squamous Cell Carcinomas (2011) (5)
Targeted, gene-directed enzyme prodrug therapies to tackle diversity and aggression of late stage prostate cancer. (2007) (5)
Correction: 3D Cultures of Prostate Cancer Cells Cultured in a Novel High-Throughput Culture Platform Are More Resistant to Chemotherapeutics Compared to Cells Cultured in Monolayer (2015) (5)
Karyotypic analysis of a heterogeneous human transitional cell carcinoma of the bladder. (1994) (4)
DNA flow‐cytometric analysis in colorectal cancer: A comparison of metastasizing and non‐metastasizing tumours (1996) (4)
KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate Cancer (2020) (4)
Detection of tumor-associated membrane proteins in prostate and bladder carcinomas by means of protein blotting (2004) (4)
High resolution proton MRS in cancer pathology (1992) (4)
Protein Expression of Epidermal Growth Factor Receptor in Laryngeal Squamous Cell Carcinoma Index Tumors Correlates with Diagnosis of Second Primary Tumors of the Upper Aero-Digestive Tract (2009) (3)
Preclinical studies of monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer (2007) (3)
Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer (2017) (3)
Cytosolic Phospholipase A2-A: A Potential TherapeuticTarget for Prostate Cancer (2008) (3)
In Vitro Assessment of Migratory Behavior of Two Cell Populations in a Simple Multichannel Microdevice (2013) (3)
Stability of lectin binding properties expressed by human bladder carcinoma cell lines passaged in vitro or in nude mice (2004) (3)
Overexpression of nm23 Protein Assessed by Color Video Image Analysis in Metastatic Colorectal Cancer: Correlation with Reduced Patient Survival (1998) (3)
Development and characterization of a human cell line from an ovarian mixed mullerian tumor (carcinosarcoma) (1988) (3)
Prolonged Antiresorptive Treatment of Lytic Prostate Cancer Xenografts in Mouse Bone Results in Tumor Necrosis (2009) (3)
Active and pro-plasminogen activator on the surface of human bladder cancer cells derived from a high grade invasive tumour. (1990) (3)
Proton MRS Can Determine the Pathology of Human Cancers with a High Level of Accuracy (2004) (2)
DNA-Flow Cytometric Analysis of Bladder TCC Using Paraffin-Embedded Tissues (1998) (2)
Second Primary Tumours of the Head and Neck are not Associated With Adverse Overall Survival in Oral Sccs (2011) (2)
Electron Microscopy of Renal Glomerular Basement Membrane Changes in Healthy Mice and in Spontaneous and Nephrotoxic Murine Nephritis (1969) (2)
Transduction of biopsy samples: bridging gene therapy between animals and humans. (2001) (2)
Raman spectroscopy for breast cancer detection: A sample processing study (2004) (2)
Abstract 4950: Hypercholesterolemia promotes prostate cancer PC-3 metastases in orthotopic xenograft mice (2014) (1)
An investigation of fludarabine as a potential radiation sensitizer of human prostate cancer cells in vitro (2008) (1)
Patient-Derived Xenograft Models of Prostate Tumors (2017) (1)
A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells (2021) (1)
Correlation between p33ING1b cytoplasmic transfer and lymph node metastasis in oral squamous cell carcinoma (2008) (1)
Argyrophilia in endometrial carcinoma (1983) (1)
Promising Tumor-Associated Antigens for Future Prostate Cancer Therapy (2010) (1)
Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1) (2018) (1)
Is Magnetic Resonance Spectroscopy the new gold standard for breast cancer diagnosis (2003) (1)
Regression analysis of defined mixtures of cancer and benign tissue in prostate biopsies (2003) (1)
Pathology Of Hepatocellular Carcinoma And Its Precursors Using Proton Magnetic Resonance And Statistical Classification Strategies (2002) (1)
Androgen decreases osteoprotegerin expression in prostate cancer cells (2007) (1)
PD-L1 expression in 522 selected sarcomas with subset analysis of recurrent or metastatic matched samples and association with tumour-infiltrating lymphocytes (2019) (1)
Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1) (2018) (1)
Human bladder cancer grown as xenografts and in tissue culture as models of the biology and treatment of invasive bladder cancer. (1988) (1)
Human bladder cancer grown as xenografts and in tissue culture as models of the biology and treatment of invasive bladder cancer. (1988) (1)
The LIGO Gravitational Wave Observatories:. Recent Results and Future Plans (2005) (1)
Post‐translation modification of proteins in tears (2010) (1)
Composition and method of killing tumors (2003) (0)
7. Immature endometrial teratoma (2012) (0)
More than a biomarker: exploring the role of glypican-1 as a new therapeutic target for prostate cancer (2016) (0)
Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: Identification of its antigen as a neutral glycolipid (1995) (0)
In vivo spectroscopy and imaging of the ovary at 3 tesla (2005) (0)
P240 Expression of Cell Cycle Regulators as Markers of Field Cancerization and Second Primary Tumors in Larynx Squamous Cell Carcinoma (2006) (0)
Abstract 4779: Circulating and tumor-infiltrating CD4+IL-17+ T-cells in mice bearing orthotopic and heterotopic prostate tumors (2010) (0)
IDENTIFICATION OF POTENTIAL BIOMARKERS FOR PROSTATE CANCER IN TEARS AND SERUM USING PROTEOMIC APPROACHES (2009) (0)
Cytosolic PhospholipaseA2-A: A Potential Therapeutic Target for Prostate Cancer (2008) (0)
Promise of Novel Magnetic Nanoparticles for Gene Therapy Application: Synthesis, Stabilisation, and Gene Delivery (2008) (0)
Magnetic resonance spectroscopy of a breast biopsy for determining pathology, vascularization of the case or the case of a nodal betrof fenheit (2000) (0)
Glypican-1: A new biomarker for the detection of prostate cancer (2016) (0)
Abstract 3040: Cavin-1 alters oncogenic effects of caveolin-1 microdomains in prostate cancer. (2013) (0)
Androgen influence on prostate cancer exosomes production and content (2013) (0)
Multimodal hyperbranched polymers for simultaneous imaging and drug delivery for targeted prostate cancer theranostics (2014) (0)
The Role of p53 Mutations in Metastasis of Prostate Cancer to Bone (2004) (0)
MR spectroscopy of ductal carcinoma in Situ (2003) (0)
The Rewards and Challenges of Interdisciplinary Graduate Education (2015) (0)
DISCUSSION. SOME NOTES ON SIGNIFICANCE OF FORM IN BRIDGE ENGINEERING. (1976) (0)
Androgen-stimulated extracellular vesicles regulate cellular proliferation in androgen deprived prostate cancer cells (2015) (0)
Book Review: Prostate Cancer Methods and Protocols (2003) (0)
LIGO: S1 Science Results and Plans Beyond (2004) (0)
Targeting neuropilin-1 to inhibit prostate cancer invasion and metastasis (2015) (0)
Enhancing MRI of prostate cancer using PSMA-targeting iron oxide magnetic nanoparticles (2014) (0)
Raman spectroscopy on breast cancer detection: sample pre-processing study (2004) (0)
Stereoselective PT complexes as probes of the mechanism of action of Pt anti-cancer drugs (1995) (0)
Abstract 4908: Neuropilin-1 is up-regulated in the adaptive response of prostate tumors to androgen targeted therapies and is prognostic of metastatic progression and patient mortality (2017) (0)
Influence of Cellular DMA Content on Survival in Advanced Ovarian Cancer (2006) (0)
Drug accumulation into single drug-sensitive and drug-resistant prostate cancer cells conducted on the single cell bioanalyzer (2014) (0)
Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism (2013) (0)
Abstract 2855: Monitoring tumor growth and oxygen distribution of prostate cancer xenograftsin vivousing ultrasound and photoacoustic imaging (2017) (0)
Androgen influence on prostate cancer secreted microvesiclesproduction and content (2014) (0)
Plenary 1: Faculty Development at Bridgewater: Davis Recommendations (2012) (0)
Stereoselective and enantioselective interactions between chiral PT complexes and DNA (1997) (0)
Diagnosis of Hepatocellular Carcinoma using Proton Magnetic Resonance Spectroscopy Ex Vivo (2001) (0)
Application of PSMA-targeting magnetic nanoparticles into MRI of prostate cancer (2013) (0)
Use of targeted magnetic nanoparticles for Magnetic Resonance Imaging of prostate cancer (2012) (0)
Control of DU145 and LNCaP-LN3 prostate cancer spheroid growth using Bi-213-labeled multiple targeted alpha radioimmunoconjugates (2005) (0)
Abstract C30: Use of targeted magnetic nanoparticles for imaging in prostate cancer (2012) (0)
Multiparametric approach to diagnose ovarian lesions preoperatively: Combination of ADC and MRS (2012) (0)
Comparison of Psma Pet/ct, Psma Pet/mr and Multiparametric Mr in the Detection of Primary Prostate Cancer (2017) (0)
BRCA1 mutation site may associate with nuclear DNA content in BRCA1-associated ovarian carcinomas (2004) (0)
Trends in axillary management of breast cancer in Auckland, New Zealand (2015) (0)
Multimodal hyperbranched polymers targeting prostate specific membrane antigen (PSMA) for imaging of prostate cancer (2015) (0)
A Themed Cluster of Honors First Year Seminars: Promoting an Interdisciplinary Understanding of Social Inequality (2016) (0)
0 50 50 41 v 2 1 2 M ay 2 00 5 Search for gravitational waves from galactic and extra – galactic binary neutron stars } (2008) (0)
Search for gravitational wave radiation associated with the pulsating tail of the SGR 1806â‹TM20 hyperflare of 27 December 2004 using LIGO (2020) (0)
Hyperbranched polymers in theranostics: Development of advanced delivery probes for cancer therapy (2013) (0)
Plasminogen activator activity in intact human bladder cancer cells (1989) (0)
HN03 HEAD AND NECK SECOND PRIMARY TUMORS IN LARYNGEAL SCC ARE NOT ASSOCIATED WITH POORER OVERALL SURVIVAL: A SINGLE CENTER STUDY IN 987 PATIENTS (2009) (0)
0 31 20 56 v 4 3 0 M ar 2 00 4 First upper limits from LIGO on gravitational wave bursts LIGO-P 030011 (2004) (0)
Prostate cancer biomarkers and the emerging proteomic techniques used in biomarker research (2012) (0)
0 50 10 68 v 3 2 4 Ju n 20 05 A Search for Gravitational Waves Associated with the Gamma Ray Burst GRB 030329 Using the LIGO Detectors LIGO-P 040007-08-D (2018) (0)
Abbott, B. and Cantley, C.A., LIGO Scientific Collaboration (2004) Setting upper limits on the strength of periodic gravitational waves from PSR (2019) (0)
Teaching Note - Toward Twenty-first-century Teaching: Interdisciplinarity at Bridgewater and Beyond (2014) (0)
Sustainability at BSU: Partnerships for Teaching, Community Outreach, and On-Campus Change (2012) (0)
Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in diagnosing localised prostate cancer (2015) (0)
What is the value of proton MRS in detecting early malignant changes (1998) (0)
T H E ROLE OF NONLYMPHOID ACCESSORY CELLS IN THE IMMUNE RESPONSE TO D I F F E R E N T ANTIGENS (0)
Targeted multimodal hyperbranched polymers for imaging and therapy of prostate cancer (2016) (0)
In vivo spectroscopy pf the ovary at 3 Tesla (2006) (0)
Title Tie-2 regulates the stemness and metastatic properties ofprostate cancer cells (2016) (0)
Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cells (2017) (0)
Augmentation of a Novel Enzyme/Pro-Drug Gene Therapy Distant Bystander Effect to Target Prostate Cancer Metastasis (2004) (0)
BRCA1 mutation site may associate with nuclear DNA content in BRCA1-associated ovarian carcinomas. (2004) (0)
Use of targeted magnetic nanoparticles for imaging in prostate cancer (2013) (0)
Formulated Delivery of Enzyme/Pro-Drug and Cytokine Gene Therapy to Promote Immune Reduction of Treated and Remote Tumors in Mouse Models of Prostate Cancer (2005) (0)
Cancer Therapy : Preclinical Molecular Chemotherapy and Chemotherapy : A New Front against Late-Stage Hormone-Refractory Prostate Cancer (2011) (0)
Prostate Specific Membrane Antigen (PSMA)-Targeting Iron Oxide Magnetic Nanoparticles (MNPs) Enhance MRI of Preclinical Prostate Cancer (2017) (0)
STUDIES OF MACROPHAGE FUNCTION IN MURINE SYSTEMIC LUPUS ERYTHEMATOSUS. 4. FAtLURE TO REVERSE THE BY IN VITRO STIMULANTS OR PROSTAGLANDINS (1986) (0)
Cytogenetics of urothelial neoplasis (2006) (0)

This paper list is powered by the following services:

Other Resources About Pamela Russell

en.wikipedia.org

What Schools Are Affiliated With Pamela Russell?

Pamela Russell is affiliated with the following schools:

Pamela Russell's Academic­Influence.com Rankings